Targeting latent HIV Astroglial Reservoirs without Reactivation
Targeting latent HIV Astroglial Reservoirs without Reactivation
批准号:
9350661
负责人:
Anuja Ghorpade
金额:
$21.9万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-05-01 至 2019-03-31
关键词:
AddressAstrocytesBiological MarkersBiological ModelsBlood - brain barrier anatomyBrainCell LineCellsChronicColorComorbidityCytomegalovirusDNADataDiseaseExcisionFailureFluorescent DyesFutureGene ExpressionGenesGoalsGuide RNAHIVHIV InfectionsHIV SeropositivityHIV therapyHIV-1HIV-associated neurocognitive disorderHomeostasisHumanIndividualInfectionInflammationInvestigationLigandsMediatingModelingMonitorNerve DegenerationNeurogliaNeurologicNeuronsPatientsPeripheral Blood Mononuclear CellPhysiologicalPopulationProvirusesRecoveryReporterResearch PersonnelSorting - Cell MovementSystemTNF geneTechniquesTherapeuticTimeTissuesVesicular stomatitis Indiana virusViralViral GenesViral ProteinsViral reservoirVirionVirusVirus DiseasesVirus LatencyWorkantiretroviral therapyastrogliosisbasecytokinedigitalextracellularimprovedinsightlatent infectionnanoparticleneuroAIDSneuroinflammationnovelnovel therapeuticspreventpromoterreceptorresponserestorationscale upsynaptic functiontargeted biomarkertherapeutic genetool
中文摘要
项目摘要/摘要
尽管抗逆转录病毒疗法(ART)取得了成功,但对人类免疫缺陷的追求
病毒(HIV)-1治疗仍在继续。为了实现彻底根除,我们必须成功地解决持久性病毒。
储藏在不同的组织隔间中。HIV相关性神经认知障碍(HAND)仍然是一种
后艺术时代的重大社会负担。针对RFA-MH-17-100,我们建议揭开
应对星形胶质细胞作为HIV-1的主要中枢神经系统储存库的策略。
我们的初步数据显示,HIV-1潜伏期可以在培养的人类星形胶质细胞中重现。缺乏
评估延迟与重新激活的强大实验工具在一定程度上是缺乏
中枢神经系统中病毒潜伏期的信息。我们建议使用强大的双色HIV-1报告病毒,
含有CMV驱动的mCherry(红色,R)和HIV-1 LTR驱动的GFP(绿色,G)。初步研究使用PRIMARY
显示感染RG-HIV-1VSV假型病毒粒子的人星形胶质细胞。所有感染RG-的星形胶质细胞-
HIV-1表达CMV驱动的小樱桃(红色),而只有那些具有活跃的HIV-1 LTR的人才会表达
绿色荧光蛋白(绿色),HIV-1 p24阳性。红色星形胶质细胞(mCherry+/GFP-)代表潜伏感染
易于监测、分类、操纵和机械调查的细胞。我们已经确立了
该模型系统采用原代人脑星形胶质细胞,提供了一个简单、方便、功能强大的工具
这些东西很管用。
我们认为,潜伏感染的星形胶质细胞表达可识别的生物标志物,即使在缺乏的情况下也是如此。
重新激活。而引导RNA/Cas9编辑可以切除或沉默前病毒基因的表达
防止复活,改善星形胶质细胞的生理功能。为了缓解……的难题
区分潜伏感染的星形胶质细胞和具有活跃HIV-1 LTR功能的星形胶质细胞,我们的第一个目标是
确定人类星形胶质细胞中HIV-1潜伏期的目标生物标记物(目标1)。第二,我们将潜伏目标
使用GUIDE RNA和Cas9基因编辑技术切除前病毒感染星形胶质细胞而不再激活
组件,使其处于静默状态且无法重新激活(目标2)。目标1和目标2的成功整合
将导致治愈和根除HIV-1中枢神经系统蓄积物的新疗法。总而言之,这些调查
响应RFA-MH-17-100将提供新的和及时的洞察力,以划定识别和
针对星形胶质细胞病毒库,HIV-1/Hand治愈的关键中枢神经系统障碍,并在没有病毒的情况下消除它们
重新激活。
英文摘要
Project Summary/Abstract
Despite the advent of successful antiretroviral therapy (ART), the quest for a human immunodeficiency
virus (HIV)-1 cure continues. In order to achieve total eradication, we must successfully resolve persistent viral
reservoirs in various tissue compartments. HIV-associated neurocognitive disorders (HAND) remain a
significant societal burden in post-ART era. In response to the RFA-MH-17-100, we propose to uncover
strategies to address astrocytes as a major CNS reservoir for HIV-1.
Our preliminary data show HIV-1 latency can be recapitulated in cultured human astrocytes. The lack of
powerful experimental tools to evaluate latency versus reactivation has in part, been responsible for the lack of
information in viral latency in the CNS. We propose to employ the powerful dual color HIV-1 reporter virus that
harbors CMV-driven mCherry (red, R) and HIV-1 LTR-driven GFP (green, G). Preliminary studies using primary
human astrocytes infected with RG-HIV-1 VSV-pseudotyped virions are shown. All astrocytes infected with RG-
HIV-1 express the CMV-driven mCherry (red), whereas only those that have an active HIV-1 LTR will express
GFP (green) and are positive for HIV-1 p24. Red-alone astrocytes (mCherry+/GFP-) represent latently infected
cells amenable to easy monitoring, sorting, manipulation and mechanistic investigations. We have established
this model system using primary human astrocytes, which presents a simple, convenient and powerful tool for
these works.
We propose that latently infected astrocytes express identifiable biomarkers, even in the absence
of reactivation. And that guide RNA/Cas9 editing can excise or silence proviral gene expression to
prevent reactivation and improve astrocyte physiological function. To mitigate the conundrum of
distinguishing latently infected astrocytes from those that have active HIV-1 LTR function, our first goal is to
identify targetable biomarkers for HIV-1 latency in human astrocytes (Aim 1). Second, we will target latently
infected astrocytes without reactivation using guide RNA and Cas9 gene editing techniques to excise proviral
components, rendering it silent and incapable of reactivation (Aim 2). A successful integration of Aims 1 and 2
will lead to novel therapies to cure and eradicate HIV-1 CNS reservoirs. In summary, these investigations
responding to RFA-MH-17-100 will provide novel and timely insight into delineating approaches to identify and
target astrocyte viral reservoirs, key CNS barriers to HIV-1/HAND cure, and eliminate them without viral
reactivation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Astrocyte-TAAR1 & METH in HAND
-
批准号:9103076
-
项目类别:
-
资助金额:$34.33万
-
财政年份:2015
-
负责人:Anuja Ghorpade
-
依托单位:
Health Disparities & sCD40L: Novel Biomarkers for HIV-1 Disease Progression
-
批准号:8511818
-
项目类别:
-
资助金额:$18.46万
-
财政年份:2013
-
负责人:Anuja Ghorpade
-
依托单位:
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury
-
批准号:8254417
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2009
-
负责人:Anuja Ghorpade
-
依托单位:
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury
-
批准号:8448346
-
项目类别:
-
资助金额:$37.54万
-
财政年份:2009
-
负责人:Anuja Ghorpade
-
依托单位:
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury
-
批准号:7786992
-
项目类别:
-
资助金额:$39.72万
-
财政年份:2009
-
负责人:Anuja Ghorpade
-
依托单位:
CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia
-
批准号:8532040
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2009
-
负责人:Anuja Ghorpade
-
依托单位:
CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia
-
批准号:7886747
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2009
-
负责人:Anuja Ghorpade
-
依托单位:
CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia
-
批准号:8109269
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2009
-
负责人:Anuja Ghorpade
-
依托单位:
CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia
-
批准号:7758688
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2009
-
负责人:Anuja Ghorpade
-
依托单位:
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury
-
批准号:7685779
-
项目类别:
-
资助金额:$39.82万
-
财政年份:2009
-
负责人:Anuja Ghorpade
-
依托单位:
CXCL8-mediated glial cross-talk and neuroprotection in HIV-1 Dementia
-
批准号:8304996
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2009
-
负责人:Anuja Ghorpade
-
依托单位:
Mechanisms and Interventions for Methamphetamine and HIV-1 Induced CNS Injury
-
批准号:8051739
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2009
-
负责人:Anuja Ghorpade
-
依托单位:
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1
-
批准号:7351838
-
项目类别:
-
资助金额:$11.7万
-
财政年份:2005
-
负责人:Anuja Ghorpade
-
依托单位:
Neuronal survival, HIV-1 and Astrocyte TIMP-1
-
批准号:8213691
-
项目类别:
-
资助金额:$39.52万
-
财政年份:2005
-
负责人:Anuja Ghorpade
-
依托单位:
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1
-
批准号:9256535
-
项目类别:
-
资助金额:$41.44万
-
财政年份:2005
-
负责人:Anuja Ghorpade
-
依托单位:
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1
-
批准号:7008587
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2005
-
负责人:Anuja Ghorpade
-
依托单位:
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1
-
批准号:7579029
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2005
-
负责人:Anuja Ghorpade
-
依托单位:
Neuronal Survival, HIV-1 and Astrocyte-TIMP-1
-
批准号:8753085
-
项目类别:
-
资助金额:$42.59万
-
财政年份:2005
-
负责人:Anuja Ghorpade
-
依托单位:
Neuronal survival, HIV-1 and Astrocyte TIMP-1
-
批准号:8016627
-
项目类别:
-
资助金额:$39.54万
-
财政年份:2005
-
负责人:Anuja Ghorpade
-
依托单位:
Neuronal survival, HIV-1 and Astrocyte TIMP-1
-
批准号:7760545
-
项目类别:
-
资助金额:$39.55万
-
财政年份:2005
-
负责人:Anuja Ghorpade
-
依托单位:
国内基金
海外基金
Ascl1介导Wnt/beta-catenin通路在TLE海马硬化中反应性Astrocytes异常增生的作用及调控机制
-
批准号:31760279
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2017
-
负责人:丁银秀
-
依托单位: